Both in Pharmaceuticals
Aurinia Pharmaceuticals vs Bausch Health Companies
Over the past year AUPH returned +48.5% and BHC returned −10.4%; their daily moves had a correlation of 0.11.
AUPH +48.5% BHC −10.4%Growth of $1, one year, split-adjusted
| Metric | AUPH | BHC |
|---|---|---|
| Price | $16.42 | $5.80 |
| Market cap | $2.18B | $2.17B |
| Today | −0.61% | +0.52% |
| 1 month | +0.8% | −8.2% |
| 6 months | +17.5% | +15.3% |
| Year to date | +2.9% | −16.5% |
| 1 year | +25.0% | −10.5% |
| Revenue growth (YoY) | +18.9% | +12.7% |
| Gross margin | 92.1% | 72.9% |
| Net margin | 45.0% | 9.0% |
| P/E (TTM) | 7.0× | — |
| Price / sales | 7.0× | 0.2× |
| Net cash | $382.7M | -$18.94B |
| Dividend yield | — | — |
| Volatility (60d) | 35.6% | 72.8% |
| Short % of float | 8.3% | 3.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).